Future research could employ more sophisticated techniques, such as gene editing and protein–protein interaction analyses, to reveal in greater detail and comprehensiveness the exact mechanisms of ATP6AP1 in the development of drug resistance in breast cancer. The gene discussed is ATP6AP1; the disease is breast carcinoma.